Gillis Carrigan

1.2k total citations
15 papers, 805 citations indexed

About

Gillis Carrigan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, Gillis Carrigan has authored 15 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 3 papers in Physiology. Recurrent topics in Gillis Carrigan's work include Lung Cancer Treatments and Mutations (4 papers), Statistical Methods in Clinical Trials (3 papers) and Asthma and respiratory diseases (3 papers). Gillis Carrigan is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Statistical Methods in Clinical Trials (3 papers) and Asthma and respiratory diseases (3 papers). Gillis Carrigan collaborates with scholars based in United States, Canada and Belgium. Gillis Carrigan's co-authors include Hubert Chen, Kenneth J. Rothman, Michael D. Taylor, Brandon Arnieri, William B. Capra, Sherry H. Stewart, Sarah Barton Samoluk, Mary S. Bradley, Aidan A. Long and Carlos Iribarren and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Epidemiology and Journal of Allergy and Clinical Immunology.

In The Last Decade

Gillis Carrigan

15 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gillis Carrigan United States 10 304 264 184 125 99 15 805
Mohammad Movahedi Canada 15 105 0.3× 73 0.3× 134 0.7× 39 0.3× 62 0.6× 76 838
Necdet B. Gunsoy United Kingdom 13 655 2.2× 846 3.2× 108 0.6× 196 1.6× 190 1.9× 33 1.1k
Chiledum Ahaghotu United States 21 406 1.3× 76 0.3× 265 1.4× 26 0.2× 108 1.1× 39 1.2k
Samuel Wagner United States 13 302 1.0× 130 0.5× 372 2.0× 15 0.1× 175 1.8× 25 1.4k
Alexa Meara United States 15 235 0.8× 52 0.2× 152 0.8× 25 0.2× 51 0.5× 49 1.2k
Annette Wigertz Sweden 16 216 0.7× 40 0.2× 335 1.8× 14 0.1× 166 1.7× 19 1.0k
Veerle Vanvoorden Belgium 13 119 0.4× 135 0.5× 257 1.4× 11 0.1× 84 0.8× 24 1.2k
J Melia United Kingdom 19 545 1.8× 18 0.1× 826 4.5× 51 0.4× 178 1.8× 50 1.4k
John Coombs United States 17 150 0.5× 85 0.3× 289 1.6× 7 0.1× 102 1.0× 45 1.4k
Laura H. Hendrix United States 15 273 0.9× 23 0.1× 313 1.7× 21 0.2× 108 1.1× 39 733

Countries citing papers authored by Gillis Carrigan

Since Specialization
Citations

This map shows the geographic impact of Gillis Carrigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillis Carrigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillis Carrigan more than expected).

Fields of papers citing papers by Gillis Carrigan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillis Carrigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillis Carrigan. The network helps show where Gillis Carrigan may publish in the future.

Co-authorship network of co-authors of Gillis Carrigan

This figure shows the co-authorship network connecting the top 25 collaborators of Gillis Carrigan. A scholar is included among the top collaborators of Gillis Carrigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillis Carrigan. Gillis Carrigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rider, Jennifer R., Asher Wasserman, Gillis Carrigan, et al.. (2024). Emulations of oncology trials using real-world data: a systematic literature review. American Journal of Epidemiology. 194(6). 1783–1793. 1 indexed citations
2.
Borghaei, Hossein, Xerxes Pundole, Laura Sangaré, et al.. (2024). Natural history of SCLC patients treated in third-line and beyond: A retrospective real world study. Lung Cancer. 193. 107819–107819. 2 indexed citations
3.
Carrigan, Gillis, Brian D. Bradbury, M. Alan Brookhart, et al.. (2022). External Comparator Groups Derived from Real-world Data Used in Support of Regulatory Decision Making: Use Cases and Challenges. Current Epidemiology Reports. 9(4). 326–337. 10 indexed citations
4.
Spira, Alexander I., Huakang Tu, Shivani Aggarwal, et al.. (2021). A retrospective observational study of the natural history of advanced non–small-cell lung cancer in patients with KRAS p.G12C mutated or wild-type disease. Lung Cancer. 159. 1–9. 33 indexed citations
5.
6.
Carrigan, Gillis, Samuel Whipple, William B. Capra, et al.. (2019). Using Electronic Health Records to Derive Control Arms for Early Phase Single‐Arm Lung Cancer Trials: Proof‐of‐Concept in Randomized Controlled Trials. Clinical Pharmacology & Therapeutics. 107(2). 369–377. 72 indexed citations
7.
Luhn, Patricia, Deborah Kuk, Gillis Carrigan, et al.. (2019). Validation of diagnosis codes to identify side of colon in an electronic health record registry. BMC Medical Research Methodology. 19(1). 177–177. 21 indexed citations
8.
Carrigan, Gillis, Samuel Whipple, Michael D. Taylor, et al.. (2019). An evaluation of the impact of missing deaths on overall survival analyses of advanced non–small cell lung cancer patients conducted in an electronic health records database. Pharmacoepidemiology and Drug Safety. 28(5). 572–581. 43 indexed citations
9.
Curtis, Melissa D., Sandra D. Griffith, Melisa Tucker, et al.. (2018). Development and Validation of a High‐Quality Composite Real‐World Mortality Endpoint. Health Services Research. 53(6). 4460–4476. 166 indexed citations
10.
Luhn, Patricia, Deborah Kuk, Gillis Carrigan, et al.. (2017). Validation of diagnosis codes to identify side of colon in an electronic health record registry.. Journal of Clinical Oncology. 35(4_suppl). 568–568. 2 indexed citations
11.
Iribarren, Carlos, Abdelkader Rahmaoui, Aidan A. Long, et al.. (2016). Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthma. Journal of Allergy and Clinical Immunology. 139(5). 1489–1495.e5. 80 indexed citations
12.
Long, Aidan A., Abdelkader Rahmaoui, Kenneth J. Rothman, et al.. (2014). Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab. Journal of Allergy and Clinical Immunology. 134(3). 560–567.e4. 150 indexed citations
13.
Namazy, Jennifer A., Michael D. Cabana, Angela E. Scheuerle, et al.. (2014). The Xolair Pregnancy Registry (EXPECT): The safety of omalizumab use during pregnancy. Journal of Allergy and Clinical Immunology. 135(2). 407–412. 149 indexed citations
14.
Namazy, Jennifer A., Michael D. Cabana, Angela E. Scheuerle, et al.. (2012). The Xolair Pregnancy Registry (EXPECT): An Observational Study Of The Safety Of Omalizumab During Pregnancy In Women With Asthma. A4221–A4221. 5 indexed citations
15.
Carrigan, Gillis, Sarah Barton Samoluk, & Sherry H. Stewart. (1998). Examination of the short form of the Inventory of Drinking Situations (IDS-42) in a young adult university student sample. Behaviour Research and Therapy. 36(7-8). 789–807. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohammad Movahedi Breakdown of academic impact, for papers by Necdet B. Gunsoy Breakdown of academic impact, for papers by Chiledum Ahaghotu Breakdown of academic impact, for papers by Samuel Wagner Breakdown of academic impact, for papers by Alexa Meara Breakdown of academic impact, for papers by Annette Wigertz Breakdown of academic impact, for papers by Veerle Vanvoorden Breakdown of academic impact, for papers by J Melia Breakdown of academic impact, for papers by John Coombs Breakdown of academic impact, for papers by Laura H. Hendrix
Rankless by CCL
2026